Ascendis Pharma A/S
ASND
$164.65
-$4.19-2.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.01M | -109.06M | -117.73M | -142.25M | -93.53M |
| Total Depreciation and Amortization | 4.27M | 4.81M | 4.72M | 4.86M | 4.84M |
| Total Amortization of Deferred Charges | 497.80K | -- | -- | -- | 520.00K |
| Total Other Non-Cash Items | 65.20M | -47.33M | 63.86M | 91.07M | 72.92M |
| Change in Net Operating Assets | -121.89M | 89.87M | -16.84M | -63.96M | -30.47M |
| Cash from Operations | -92.93M | -61.71M | -65.99M | -110.28M | -45.72M |
| Capital Expenditure | -446.60K | -513.40K | -368.10K | -216.00K | 67.80K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 1.02M | -- | 5.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.30K | -39.60K | 0.00 | 7.98M | 7.09M |
| Cash from Investing | -409.30K | -553.00K | 654.40K | 7.77M | 7.16M |
| Total Debt Issued | 0.00 | 134.16M | -- | -- | -3.53M |
| Total Debt Repaid | -2.95M | -2.81M | -2.82M | -2.79M | -2.74M |
| Issuance of Common Stock | 22.33M | 296.53M | 365.00K | 21.21M | 2.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.81M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.29M | -- | -- | -- | -- |
| Cash from Financing | 92.70K | 470.39M | -2.64M | 20.00M | -6.52M |
| Foreign Exchange rate Adjustments | 22.92M | -4.86M | 1.74M | 4.43M | -7.78M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.32M | 403.27M | -66.24M | -78.08M | -52.86M |
